We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Roche's New Lab Automation Solutions Enjoying Strong Market Response

By LabMedica International staff writers
Posted on 20 Aug 2013
New lab automation solutions from Roche (Basel, Switzerland) are driving innovation in core lab and point of care (POC) settings.

Development of new instruments and software for totally automated lab workflows and information management resulted in major business gains for the company in the first half of 2013. More...
These include recent customer acquisitions in emerging markets in Europe, the Middle East, and Africa (EMEA), Asia, and Latin America.

Roche is continuing to expand its workflow automation and IT portfolio in response to the increasing volumes of laboratory data and an increasingly regulated laboratory environment.

“Roche’s workflow optimization lineup now covers every customer segment, from small to large laboratories and all hospital point-of-care settings. With more than 20 years of industry experience and over 4000 cobas IT solutions installed globally Roche Diagnostics has a strong commitment to automation and IT,” stated Georgios Spitadakis, global head of workflow & IT at Roche Professional Diagnostics.

The new cobas 8100 automated workflow solution, introduced at EuroMedLab conference in Milan (Italy) in May 2013, is already generating a strong customer response and initial preorders. It is the result of 35 years of partnership between Roche and Hitachi High Technologies. The system made its US debut at the annual meeting of the American Association for Clinical Chemistry (AACC) in Houston, (Texas, USA). cobas 8100 combined with Roche’s cobas IT solutions gives labs full and transparent control over their operational and clinical processes in both single and multisite set-ups.

Combined with Roche’s sample archiving solutions, cobas 8100 provides flexibility and connectivity, simplifying and speeding up routines for analysis, archiving, and on-demand retrieval of blood samples. Its design helps high-throughput laboratories to consolidate processes. cobas 8100 is expected to be available this autumn in all regions outside the US, while its market availability in the North American Region is estimated for 2015.

A fully automated cobas sample flow management solution was introduced by Roche based on a modular conveyor system. Designed for laboratories in the high throughput segment, the cobas connection modules reduce manual intervention and enable laboratory professionals to increase the predictability of patient result turnaround times by up to 90%. Among the first large laboratory customers is Eone Laboratories in Songdo (Korea). Eone switched its whole automation array to cobas connection modules, which connect nine lines of cobas 8000 analyzers.

Roche’s latest advance in customized IT applications for totally automated laboratory workflows is cobas IT middleware. This solution makes it easy to link multiple laboratory systems and software applications to a facility’s IT infrastructure. “The transition to cobas IT middleware was very easy to do and very little training was needed,” commented Ake Akerbloom, clinical biologist at Oestersund Hospital in Oestersund/Sweden. cobas IT middleware has enjoyed rapid uptake since its launch in January 2013.

cobas POC IT is a fully open connectivity solution that provides access to Roche and non-Roche POC devices, including the laboratory and hospital information systems. This enables patient data from remote, handheld bedside testing devices to be managed and controlled from a single point.

Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life, and survival of patients. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

Related Links:

Roche




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.